# UK Commission Recommends Health AI Safeguards

The UK National Commission into the Regulation of AI in Healthcare recommended lifecycle safeguards for health AI, including staged authorisation, ongoing performance monitoring, version tracking and proportionate patient notice. The recommendations are advisory and do not change current legal duties. For procurement teams, the near-term opportunity is the MHRA–Manchester University NHS Foundation Trust health-innovation sandbox and potential demand for clinical evidence, monitoring, interoperability and regulatory support. The MHRA set September 2026 as its target to respond and begin operationalising the framework; full implementation is planned for 2027, subject to any required legislation. No RFP or contract award is identified.

- Health AI suppliers and service providers can assess how their offerings support the proposed lifecycle safeguards, particularly evidence generation, performance monitoring and version control.
- The MHRA–Manchester University NHS Foundation Trust sandbox is a concrete route for engagement around health-innovation work; the signal does not identify a solicitation or funding commitment.
- Procurement professionals can use the proposed framework as a planning indicator for potential clinical evidence, interoperability and regulatory-support needs, while distinguishing advisory recommendations from current legal requirements.

**Jurisdictions:** international
**Industries:** Healthcare, Information Technology
**Topics:** Artificial Intelligence, Regulatory Compliance
**Published:** September 30, 2026

### Government Entities
- Medicines and Healthcare products Regulatory Agency (MHRA)
- National Commission into the Regulation of AI in Healthcare
- Manchester University NHS Foundation Trust

### Sources
- [UK Panel Proposes Lifecycle Safeguards for Health AI](https://streamlinefeed.co.ke/news/uk-panel-proposes-lifecycle-safeguards-for-health-ai) - streamlinefeed.co.ke